Authors | Page 52

Latest:

Compliance and Reporting The Case for a Single System

Pharmaceutical companies are awash in a sea of compliance regulations that affect their business operations both inside and outside the US.

Josh Baxt

Latest:

Pharm Exec's 2018 Pipeline Report

Analysis shows that persistence is paying off for drug developers, driven by the rise of CAR-T and other gene therapy, newly discovered cancer targets, better patient identification methods-and the realization that failures have their place in shaping the pipeline of tomorrow.

David Dalke

Latest:

New Patent-Defense Path for Pharma

Inter Partes Review can potentially offer a more economical and streamlined litigation strategy for pharma and biotech players, writes David Dalke.

IMsci

Ashley Roberts

Latest:

Planning for the Future of Serialization

Compliance with the new traceability requirements necessitates an understanding of how and when to begin implementing changes in an ever-evolving industry.

Caitlin McQuilling

M. Andrew Holtman

Latest:

Crowdfunding: The Open-Source Option Against Capital Crunch

Is crowdfunding an attractive alternative to finance pharma and biotech start-ups? Seth R. Ogden and M. Andrew Holtman report.

Seth R. Ogden

Latest:

Crowdfunding: The Open-Source Option Against Capital Crunch

Is crowdfunding an attractive alternative to finance pharma and biotech start-ups? Seth R. Ogden and M. Andrew Holtman report.

Rick Koonce

Latest:

Executive Coaching: Transforming Big Pharma from Within

Defining the critical coaching steps necessary for top managers to realize their potential in an industry undergoing significant restructuring of human and financial capital.

Michael Swanick

Latest:

Brexit Report: What's Next for the Industry?

As the UK exits the European Union, the pharmaceutical and life sciences industries should prepare for changes by identifying key business issues, mitigating risks and creating plans for multiple scenarios.

Lee Jones

Latest:

The Human Microbiome—Our Body's Secret Weapon

New research on the role of microbes in fighting disease is transforming the way medicine views bacteria, writes Lee Jones.

Barbara Blasso

ghg

Cardinal Health Specialty Solutions

Rory Mullen

Latest:

Ireland’s Role in the European Union’s Evolving Pharmaceutical Sector

Rory Mullen outlines Ireland’s importance to multinational pharma in the changing EU landscape.

Julian Upton, online editor, <i>Pharmaceutical Executive</i>

Justin Works

Latest:

The Fruits of Comparative Effectiveness

New CER tools grant payers the evidence they need to control drug costs

Latest:

Plant Management

We ask three managers building Greenfield plants to rationalize and defend their decisions

Amy Ritter

Latest:

FDA Feels Pinch of House Funding Cuts

The House Appropriations Committee released the fiscal year 2013 Agriculture Appropriations bill, which, sets proposed spending levels for FDA as well as for other programs.

Adam Sherlock

Latest:

AI-based Social Listening as Aid to Pharmacovigilance

How artificial intelligence can help pharma filter out the online noise when monitoring for safety signals on the web.

Focus Reports

Latest:

Country Report: The Czech Republic

Although still tightly regulated, healthcare industry stakeholders-buoyed by regulatory reforms aimed at increasing patient access to innovative new therapies-are cautiously optimistic that the Czech Republic will further close the gap with Western Europe.

Anita Chawla

Latest:

The Fruits of Comparative Effectiveness

New CER tools grant payers the evidence they need to control drug costs

Worldwide Clinical Trials

Peter Dillman

Latest:

A Forecasting Rx for Pharmacy Benefit Managers

Building an effective drug forecasting model today requires a revamped approach.

Ted Miller